Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,805.50p on 26-12-2025 at 05:12:24
Change 0.00p 0%
Buy 1,801.50p
Sell 1,800.00p
Last Trade: Sell 33,000.00 at 1,805.50p
Day's Volume: 0
Last Close: 1,805.50p
Open: 0.00p
ISIN: GB00BN7SWP63
Day's Range 0.00p - 0.00p
52wk Range: 1,242.50p - 1,853.50p
Market Capitalisation: £72.84b
VWAP: 0.00p
Shares in Issue: 4.03b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 33,000 1,805.50p SI Trade
12:42:51 - 24-Dec-25
Unknown* 67,000 1,805.50p Negotiated Trade
OTC Trade
12:37:13 - 24-Dec-25
Buy* 338 1,805.50p SI Trade
12:35:23 - 24-Dec-25
Buy* 604,384 1,805.50p Suspected BUY Trade
12:35:23 - 24-Dec-25
Buy* 343 1,800.50p Automatic Execution
12:29:51 - 24-Dec-25
Sell* 1 1,800.4978p Ordinary
12:29:50 - 24-Dec-25
Sell* 68 1,800.00p Automatic Execution
12:29:27 - 24-Dec-25
Sell* 261 1,800.00p Automatic Execution
12:29:27 - 24-Dec-25
Buy* 1 1,800.50p SI Trade
12:29:11 - 24-Dec-25
Unknown* 0 1,800.50p SI Trade
12:28:57 - 24-Dec-25
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
26th Dec 2025 (Fri) 1,805.50 1,805.50 1,805.50 1,805.50 0
25th Dec 2025 (Thu) 1,805.50 1,805.50 1,805.50 1,805.50 0
24th Dec 2025 (Wed) 1,803.50 1,806.00 1,793.00 1,805.50 1,461,989
23rd Dec 2025 (Tue) 1,809.50 1,823.00 1,805.00 1,814.50 5,326,874
22nd Dec 2025 (Mon) 1,808.50 1,820.50 1,803.50 1,810.00 6,966,644
19th Dec 2025 (Fri) 1,805.00 1,822.00 1,798.50 1,822.00 20,121,835
18th Dec 2025 (Thu) 1,817.50 1,820.00 1,797.50 1,812.50 7,352,624
17th Dec 2025 (Wed) 1,826.00 1,850.50 1,823.50 1,833.50 10,914,252
16th Dec 2025 (Tue) 1,844.50 1,850.00 1,816.00 1,819.50 7,636,767
15th Dec 2025 (Mon) 1,819.00 1,838.50 1,810.00 1,833.50 10,789,160
12th Dec 2025 (Fri) 1,816.50 1,837.50 1,815.00 1,824.50 11,917,084
11th Dec 2025 (Thu) 1,805.00 1,821.00 1,792.50 1,821.00 8,075,205
10th Dec 2025 (Wed) 1,780.00 1,807.50 1,769.50 1,803.50 6,940,061
9th Dec 2025 (Tue) 1,821.00 1,822.50 1,780.00 1,783.00 8,159,545
8th Dec 2025 (Mon) 1,812.50 1,822.00 1,802.50 1,820.50 5,964,130
5th Dec 2025 (Fri) 1,826.50 1,833.00 1,796.00 1,805.00 4,275,273
4th Dec 2025 (Thu) 1,827.50 1,853.50 1,818.50 1,826.00 9,013,434
3rd Dec 2025 (Wed) 1,835.00 1,848.50 1,830.00 1,833.00 9,068,561
2nd Dec 2025 (Tue) 1,786.50 1,828.00 1,781.50 1,819.00 8,473,958
1st Dec 2025 (Mon) 1,790.50 1,823.00 1,783.00 1,800.00 12,290,851
28th Nov 2025 (Fri) 1,809.50 1,809.50 1,785.50 1,791.00 4,299,102
27th Nov 2025 (Thu) 1,805.00 1,812.00 1,795.50 1,802.00 8,413,515
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
22nd Dec 2025 3:30 pm RNS Director/PDMR Shareholding
22nd Dec 2025 3:30 pm RNS Director/PDMR Shareholding
22nd Dec 2025 7:00 am RNS GSK to lower drug prices and expand access in US
22nd Dec 2025 7:00 am RNS GSK to lower drug prices and expand access in US
22nd Dec 2025 7:00 am RNS Transaction in Own Shares
22nd Dec 2025 7:00 am RNS Transaction in Own Shares
19th Dec 2025 7:00 am RNS Transaction in Own Shares
19th Dec 2025 7:00 am RNS Transaction in Own Shares
18th Dec 2025 7:00 am RNS Transaction in Own Shares
17th Dec 2025 7:00 am RNS Exdensur (depemokimab ulla) approved by US FDA
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

24th Dec 2025 13:14

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought some life to proceedings. Read More

LONDON MARKET OPEN: FTSE mixed in shortened Christmas Eve trade

24th Dec 2025 09:17

(Alliance News) - Stock prices in London opened modestly lower on Wednesday, during a shortened trading session ahead of the Christmas holiday break. Read More

IN BRIEF: GSK announces drug price deal with US government

19th Dec 2025 22:11

GSK PLC - London-based pharmaceuticals firm - Announces agreement with the US government to lower the cost of prescription medicines for American patients, including GSK's portfolio for respiratory conditions such as asthma and COPD. Says it will lower the price of certain medicines in Medicaid and "launch new products with a more balanced pricing approach", and will make most of its inhaled respiratory portfolio and other products available to patients on a direct purchasing platform with savings of up to 66%. Furthermore, it intends to further support the US supply chain for critical medicines by securing a reserve of albuterol, the active ingredient used in many inhalers to relieve the symptoms of asthma and COPD, for the US. Read More

LONDON MARKET CLOSE: FTSE 100 and sterling rise after BoE rate cut

18th Dec 2025 17:16

(Alliance News) - Stock prices in London closed in the green on Thursday, following the Bank of England's decision to cut rates and a hold from the European Central Bank. Read More

GSK secures US FDA approval for "innovative" severe asthma treatment

17th Dec 2025 09:50

(Alliance News) - GSK PLC on Wednesday said its Exdensur treatment, depemokimab, for severe asthma has been approved by the US Food & Drug Administration. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value9,870.68
Change-18.54

Login to your account

Forgot Password?

Not Registered